TotalMarketCap

Dare Bioscience

DARENasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$12.274 M

$0.62 -5.73%

Close of 6 Nov 2026

As of 6 Nov 2026, Dare Bioscience (DARE) has a market capitalization of $12.3M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$1.03M

#3454 by revenue

Earnings

-$13.4M

Loss-making

Shares outstanding

15,289,502

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #402LipocineLPCN$12.6M
  2. #403Bolt BiotherapeuticsBOLT$12.6M
  3. #404Dare BioscienceDARE$12.3M
  4. #405BiofronteraBFRI$12.0M
  5. #406Tvardi TherapeuticsTVRD$11.5M

What if Dare Bioscience were worth as much as…

Open the what-if tool →

Gold $28.2T

$1,435,597

Per share 2,300,636× higher

Bitcoin $1.53T

$77,677.65

Per share 124,483× higher

Apple $5.02T

$255,008.46

Per share 408,667× higher

Or at a round number

$20.0M$50.0M$100.0M$200.0M

Where these numbers come from

Share counts and financials for Dare Bioscience are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.